ArticleEuropean journal of clinical pharmacology2017
Benefits of a national network of drug information centres: RELIS.
Article in European journal of clinical pharmacology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed.
- Trial
- Exploring virtual delivery of academic detailing to general practitioners compared with in-person delivery: a qualitative study.BMJ open quality · 2024Article
- Factors Determining Quality of Drug Information by Hospital Pharmacies-Results from Five-Year Annual Quality Assessment.Pharmacy (Basel, Switzerland) · 2024Article
- Identifying target areas of medicines information efforts to pregnant and breastfeeding women by reviewing questions to SafeMotherMedicine: A Norwegian web-based public medicines information service.BMC pregnancy and childbirth · 2022Article
- Review of Clinical Questions Submitted to Norwegian Drug Information Centres Concerning Administration and Dosage to Older Patients of Relevance to Patient-Centric Care.Pharmaceutics · 2021Article
- Quetiapine, Misuse and Dependency: A Case-Series of Questions to a Norwegian Network of Drug Information Centers.Drug, healthcare and patient safety · 2021Article
- SafeMotherMedicine: Aiming to Increase Women's Empowerment in Use of Medications During Pregnancy and Breastfeeding.Maternal and child health journal · 2020Article
- Review of Questions Concerning Clinical Drug Interactions in ADHD Treatment From Physicians in Norway.Frontiers in pharmacology · 2020Article
- Disproportionality analysis for identification of drug safety signals in a database shared by the Norwegian network of drug information centres (RELIS).European journal of clinical pharmacology · 2019Article
- Norwegian drug information centres strongly promote person-centred and personalised medicine: a brief report on the achievements and strategy.The EPMA journal · 2019Review
- Use of References in Responses from Scandinavian Drug Information Centres.Medicines (Basel, Switzerland) · 2018Article
- Informativeness of patient initial reports of adverse drug reactions. Can it be improved by a pharmacovigilance centre?European journal of clinical pharmacology · 2017Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.